Concepedia

Kevin Moulder

KM

11

Publications

505

Citations

11

H-Index

1989

Active since

Affiliations

BOKU University(Current)

New Frontier

National Institute of Allergy and Infectious Diseases

Kevin Moulder is an author at BOKU University specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1989–2019

11

Publications

11

Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator

Ruolin Lu, Chad E. Groer, Peter A. Kleindl et al. · Journal of Controlled Release · 2019 · 82 citations · Full text

Endocytosis and recycling of the complex between CD23 and HLA‐DR in human B cells

Sophia N. Karagiannis, John Warrack, K.H. Jennings et al. · Immunology · 2001 · 75 citations · Full text

Alefacept selectively promotes NK cell‐mediated deletion of CD45R0<sup>+</sup> human T cells

Joanne C. Cooper, Geoffrey Morgan, Susanne Harding et al. · European Journal of Immunology · 2003 · 63 citations · Full text

, , +16

The mouse vitronectin receptor is a T cell activation antigen.

Kevin Moulder, K Roberts, Ethan M. Shevach et al. · The Journal of Experimental Medicine · 1991 · 52 citations · Full text

, , +16

IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII)

Gary Christie, A. D. Barton, Brian Bolognese et al. · European Journal of Immunology · 1997 · 50 citations

Rows per page

1–5 of 11